PDCD1LG2 and plasma cell myeloma: Guo et al. demonstrated that PD-L1 and PD-L2 blocking on myeloma cells by the relevant blocking antibodies significantly improved the expanded NK cell cytotoxicity against myeloma cells in vitro (7).